Cargando…
Probiotics as Adjunctive Treatment for Patients Contracted COVID-19: Current Understanding and Future Needs
The coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which rages all over the world and seriously threatens human life and health. Currently, there is no optimal treatment for COVID-19, and emerging evidence found tha...
Autores principales: | Peng, Jiangying, Zhang, Meng, Yao, Guoqiang, Kwok, Lai-Yu, Zhang, Wenyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222530/ https://www.ncbi.nlm.nih.gov/pubmed/34179059 http://dx.doi.org/10.3389/fnut.2021.669808 |
Ejemplares similares
-
Editorial: Next-generation prebiotics and probiotics: Current status and future development
por: Shang, Qingsen
Publicado: (2022) -
Lactobacillus casei Zhang exerts probiotic effects to antibiotic-treated rats
por: Yao, Guoqiang, et al.
Publicado: (2021) -
Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions
por: Ban, Quan-Yao, et al.
Publicado: (2022) -
Modulation of gut mucosal microbiota as a mechanism of probiotics‐based adjunctive therapy for ulcerative colitis
por: Chen, Ping, et al.
Publicado: (2020) -
Ketogenic diet: a potential adjunctive treatment for substance use disorders
por: Kong, Deshenyue, et al.
Publicado: (2023)